[Prevalence of serologic markers of hepatitis A, B, C, and D viruses in pregnant women].
OBJECTIVE
To determine the seroprevalence of hepatitis A, B, C and D virus infection among pregnant women attending a perinatal care hospital.


METHODS
A prospective study was carried out to determine the seroprevalence of hepatitis A virus IgG antibodies (anti-HAV), hepatitis B virus markers (anti-HBcAg and HBsAg) and hepatitis C virus antibodies (anti-HCV) in pregnant women. In HBsAg positive cases. HBeAg and hepatitis D virus antibodies (anti-HDV) were investigated. All analyses were performed with the ELISA technique.


RESULTS
Of the 1500 pregnant women studied. 93.3% were positive for anti-HAV IgG. The HBsAg seroprevalence was 0.26% and anti-HCV seroprevalence was 0.53%. There were no patients with HBeAg or anti-HDV.


CONCLUSIONS
A higher seroprevalence of HBsAg was found in this study than in other studies of pregnant Mexican women. We propose that HBsAg screening become a routine prenatal test.
Ortiz-Ibarra
F J
FJ
Departmento de Infectología e Inmunología, Instituto Nacional de Perinatología (INPer), México.
Figueroa-Damián
R
R
Lara-Sánchez
J
J
Arredondo-García
J L
JL
Ahued-Ahued
J R
JR
D005260:Female; D006506:Hepatitis A / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood*; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D003699:Hepatitis D / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000453:epidemiology*; D015995:Prevalence; D016036:Seroepidemiologic Studies
D006508:Hepatitis Antibodies
Prevalencia de marcadores serológicos de los virus de la hepatitis A, B, C y D en embarazadas.